Kevin Klein (PhD) is a research fellow at Utrecht University and senior consultant at Exon Consultancy working in the field of pharmaceutical policy and regulation. He has a background in Bio-Pharmaceutical Sciences with a specialisation in Science Based Business from Leiden University and 9 years’ experience in research and consulting. Kevin obtained a PhD on regulation of complex medicines from the WHO Collaborating Centre for Pharmaceutical Policy and Regulation, of the division of Pharmacoepidemiology and Clinical Pharmacology of Utrecht University. During his work as a consultant he was involved in a number of projects on regulatory science topics around complex medicines, biologics, pharmacovigilance and new regulatory approaches to accelerate patients’ access to medicines.